Commercializing new drugs and medical devices is expensive & full of risks. EMMA’s risk management specialists can help you manage risk through pharma corporate compliance programs that include developing standards, policies and procedures, employee training, auditing and monitoring, and more.
Whether your company is commercializing its first drug or growing its portfolio, building an effective corporate compliance infrastructure is good business.
Managing the risks of commercializing a drug helps protect the significant investment your company has made in bringing that drug to market.
The elements of an effective pharma corporate compliance program are tools designed to manage risk.
Senior Management and the Board of Directors are responsible for overseeing the development and evaluation of an effective corporate compliance program.